"Already 13 vaccines are at the stage of clinical trials, among them there are both inactivated vaccines and vaccines based on the adenoviral vector," TASS quotes him.
At the same time, the study of four vaccines in these two technical areas has entered the third phase.
"To date, about 60 thousand study participants have been vaccinated, we have not received reports of serious adverse reactions, the drugs have previously shown safety," said a spokesman for the Ministry of Science and Technology of China.
Earlier, China joined the international COVAX mechanism to ensure equal access to vaccines against coronavirus infection.